Clinical trial
Metabolic Mapping to Measure Retinal Metabolism
NCT00385333 · National Eye Institute (NEI), NIH · Completed
Key facts
| NCT number | NCT00385333 |
|---|---|
| Title | Metabolic Mapping to Measure Retinal Metabolism |
| Official title | A Novel Non-Invasive In Vivo Imaging System to Measure Retinal Metabolism |
| Lead sponsor | National Eye Institute (NEI), NIH |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Macular Degeneration, Diabetic Retinopathy, Hippel-Landau Disease, Mitochondria |
| Intervention type | Procedure |
| Interventions | Feasibility Study - Imaging System |
| Enrollment | 28 |
| Start date | Sep 29, 2006 |
| Primary completion | Jun 1, 2008 |
| Completion | Sep 16, 2010 |
| First posted | Oct 9, 2006 |
| Last update posted | Jul 2, 2017 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: